Polycystic is short for polycystic ovary syndrome. Patients with polycystic ovary syndrome are usually associated with insulin resistance, metabolic disorders, and other related symptoms, and as a result, there is a higher risk that the child will be born with abnormalities and that the child may be unhealthy.
Polycystic ovary syndrome is usually due to genetic or environmental factors, and patients are typically characterized by abnormal menstruation and ovulation, hyperandrogenism, insulin resistance, and metabolic disorders.
It can lead to decreased chances of pregnancy, and there is the possibility of inducing acne, obesity, acanthosis nigricans, and abnormal lipid metabolism. It can adversely affect the gestational period.
Insulin resistance in pre-pregnancy and early pregnancy increases the incidence of diabetes mellitus, hypertension and pre-eclampsia during pregnancy, which may lead to serious conditions such as placental insufficiency, miscarriage, congenital malformations, preterm labor, and stillbirth.
Patients also have an elevated rate of first cesarean section and increased neonatal complications, along with an increased risk of obesity, insulin resistance and diabetes mellitus in the fetus as an adult.
To summarize, children born to patients with polycystic ovary syndrome have a higher chance of being unhealthy, and patients should actively treat the primary disease before considering pregnancy.